Trump administration pick for Health and Human Services department could cause rise in preventable disease, health expert ...

Former FDA Commissioner Scott Gottlieb, who served in the first Trump administration, is raising concerns with Republicans ...

Scott Gottlieb said he’s worried that Trump’s pick to run HHS, Robert F. Kennedy Jr., will follow through on past antivaccine ...

Scott Gottlieb, the former commissioner of the Food and Drug Administration (FDA) during President-elect Trump’s first term, ...

GEN highlights six AI-based drug discoverers worthy of note based on pipeline or platform progress, and in one instance, a ...

Dr. Reddy’s Laboratories RDY announced that it has launched a biosimilar of Coherus BioSciences’ CHRS Loqtorzi (toripalimab) ...

Despite Pfizer 's ( PFE 0.23%) recent struggles with falling earnings and a bid by an activist investor to unseat its ...

For me at the moment, the stock I'm wishing I held in my portfolio is Palantir Technologies (NASDAQ: PLTR). Why do I wish I ...

Mean duration of Crohn's disease was 7.4 years. Nearly half (48.5%) had previous biologic therapy failure, 45.7% had previous ...

As COVID-19 is expected to surge this winter, communities across the Southwest face rising hospitalizations and new, ...

We are grateful to our colleagues for their interest and thoughtful comments on our Seminar about systemic lupus erythematosus (SLE).1 We appreciate the remarks from Qihe Xu, and Thomas Pabst and ...

Is the healthcare stock in big trouble and headed for a greater decline, or are investors perhaps a bit too bearish on the ...